tris(2-carboxyethyl)phosphine has been researched along with Canine Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Henklewska, M; Obminska-Mrukowicz, B; Pawlak, A; Pruchnik, H | 1 |
| Lehner, AF; Rumbeiha, WK; Samsing, F | 1 |
2 other study(ies) available for tris(2-carboxyethyl)phosphine and Canine Diseases
| Article | Year |
|---|---|
Complex of Platinum(II) with Tris(2-carboxyethyl)phosphine Induces Apoptosis in Canine Lymphoma/Leukemia Cell Lines.
Topics: Animals; Apoptosis; Cell Cycle; Cell Line, Tumor; Dog Diseases; Dogs; Leukemia, B-Cell; Lymphoma, B-Cell; Lymphoma, T-Cell; Organoplatinum Compounds; Phosphines | 2017 |
Organophosphate ester flame retardant-induced acute intoxications in dogs.
Topics: Acute Disease; Administration, Oral; Animals; Dog Diseases; Dogs; Esters; Fatal Outcome; Female; Flame Retardants; Male; Neurotoxicity Syndromes; Phosphines; Poisoning; Seizures | 2010 |